Metric Deep Dive: Understanding IO Biotech Inc (IOBT) Through its Ratios

Kiel Thompson

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

After finishing at $0.56 in the prior trading day, IO Biotech Inc (NASDAQ: IOBT) closed at $0.56, up 0.25%. In other words, the price has increased by $0.25 from its previous closing price. On the day, 0.53 million shares were traded. IOBT stock price reached its highest trading level at $0.59 during the session, while it also had its lowest trading level at $0.56.

Ratios:

Our goal is to gain a better understanding of IOBT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.01 and its Current Ratio is at 2.01. In the meantime, Its Debt-to-Equity ratio is 19.91 whereas as Long-Term Debt/Eq ratio is at 19.04.

Morgan Stanley Downgraded its Overweight to Equal-Weight on September 30, 2025, while the target price for the stock was maintained at $0.39.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 30 ’25 when Hunter Heidi bought 15,000 shares for $1.39 per share. The transaction valued at 20,884 led to the insider holds 15,000 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOBT now has a Market Capitalization of 40464028 and an Enterprise Value of 27919028.

Stock Price History:

The Beta on a monthly basis for IOBT is 0.50, which has changed by -0.3487833 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, IOBT has reached a high of $2.79, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is -24.51%, while the 200-Day Moving Average is calculated to be -52.57%.

Shares Statistics:

The stock has traded on average 2.50M shares per day over the past 3-months and 774910 shares per day over the last 10 days, according to various share statistics. A total of 69.69M shares are outstanding, with a floating share count of 58.90M. Insiders hold about 18.13% of the company’s shares, while institutions hold 37.33% stake in the company. Shares short for IOBT as of 1765756800 were 2015986 with a Short Ratio of 0.81, compared to 1763078400 on 2426960. Therefore, it implies a Short% of Shares Outstanding of 2015986 and a Short% of Float of 5.35.

Earnings Estimates

The dynamic stock of IO Biotech Inc (IOBT) is currently attracting attention from 1.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.11 and low estimates of -$0.23.

Analysts are recommending an EPS of between -$0.88 and -$0.88 for the fiscal current year, implying an average EPS of -$0.88. EPS for the following year is -$0.36, with 1.0 analysts recommending between -$0.36 and -$0.36.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.